A Preview Of Bionano Genomics's Earnings
Portfolio Pulse from Benzinga Insights
Bionano Genomics (NASDAQ:BNGO) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.94. The company's past performance shows a trend of missing EPS estimates, which has led to share price drops. The stock is currently trading at $1.63, down 92.9% over the last 52-week period.
November 07, 2023 | 6:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Bionano Genomics is expected to report an EPS of $-0.94. The company's history of missing EPS estimates and the subsequent negative impact on its share price may influence investor sentiment.
Bionano Genomics has a history of missing EPS estimates, which has led to drops in its share price. Given this trend and the current analyst estimate of $-0.94 EPS, there is a high likelihood of a negative short-term impact on the company's stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100